CMAX
Live / Registered — Registered (as of 23 Aug 2022)
What this means for you
Registered since 23 Aug 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Aug 2028: the §8 declaration of use).
Record
- Serial number
- 88674141
- Registration number
- 6828135
- Mark type
- Word mark
- Filed
- 30 Oct 2019
- Published for opposition
- 30 Jun 2020
- Registered
- 23 Aug 2022
- Next maintenance filing
- §8 declaration of use, due by 23 Aug 2028 (grace period to 23 Feb 2029)
- Attorney of record
- Christina M. Licursi, Esq.
Goods and services
- Class 001 — Chemicals: biologics, namely, antibodies, and antigens for in vitro scientific or research use, all produced by engineered microbial cells, microbes and/or microbial systems; microbial cells, microbes, and microbial systems for use in the manufacture of biologics including antibodies, antigens, and vaccines
- Class 005 — Pharmaceuticals: biologics, namely, antibodies, antigens, and vaccines all for medical purposes and produced by engineered microbial cells, microbes and/or microbial systems
Owner
- Conagen Inc., Bedford, MA, US
- Conagen Inc., Bedford, MA, US
- Conagen Inc., Bedford, MA, US
Prosecution history
- 23 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 22 Jul 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jul 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Feb 2022 — USE AMENDMENT FILED
- 25 Feb 2022 — TEAS STATEMENT OF USE RECEIVED
- 03 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2021 — CORRECTED NOA E-MAILED
- 02 Sept 2021 — SOU EXTENSION 2 GRANTED
- 25 Aug 2021 — SOU EXTENSION 2 FILED
- 02 Sept 2021 — DIVISIONAL PROCESSING COMPLETE
- 25 Aug 2021 — DIVISIONAL REQUEST RECEIVED
- 25 Aug 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 30 Aug 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL